You need to sign in or sign up before continuing.


  • Br J Anaesth · Feb 1997

    Clinical Trial

    Use of heparinase modified thrombelastography in liver transplantation.

    • S A Harding, S V Mallett, T D Peachey, and D J Cox.
    • Department of Anaesthesia and Intensive Care, Royal Free Hospital, London.
    • Br J Anaesth. 1997 Feb 1;78(2):175-9.

    AbstractSevere coagulopathies can occur during liver transplantation, particularly after reperfusion of the grafted liver. Heparin release has been proposed as one of the factors contributing to this coagulopathy. We have analysed the thrombelastograph (TEG) traces of 55 patients after reperfusion using native and heparinase-treated samples. In almost all cases an abnormal native TEG was improved in vitro by heparinase, demonstrating the presence of heparin or a heparin-like substance. The heparinase-modified TEG allowed assessment of the underlying coagulation status, providing a rational guide to blood component replacement or treatment of fibrinolysis.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…